Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

WP760, a melanoma selective drug.

Cancer chemotherapy and pharmacology | 2007

Our goal was to perform studies on the specificity and antimelanoma mechanism of a novel bis-anthracycline, WP760. WP760 initially identified in the NCI 160 screen as anti-melanoma.

Pubmed ID: 17195067 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, United States
    Id: CA P30 16672
  • Agency: NCI NIH HHS, United States
    Id: CA R41 109862
  • Agency: NCI NIH HHS, United States
    Id: CA-R01 090282
  • Agency: NCI NIH HHS, United States
    Id: P50 CA09345926
  • Agency: NCI NIH HHS, United States
    Id: T-32 CA 73954

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.